Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

[Expression of extracellular matrix metalloproteinase inducer in the unstable plaque of patients with acute coronary syndrome].

Wang B, Xu SS, Jiang JJ, Lu XB, Xue YS, Wang JC, Mi YF, Zhu M, Ge WL, Tang LJ.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 May;40(5):416-20. Chinese.

PMID:
22883094
2.

Clinical significance of leukotriene b4 and extracellular matrix metalloproteinase inducer in acute coronary syndrome.

Xu S, Tang L, Mi Y, Jiang J, Zhu M, Chen B, Wang B, Li T, Xu C, Wang J, Lu X, Ge W, Wang L, Huang J.

Clin Invest Med. 2013 Dec 1;36(6):E282-9.

PMID:
24309224
3.
4.

Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-κB pathway.

Fan Y, Wang J, Wei L, He B, Wang C, Wang B.

Int J Cardiol. 2011 Oct 6;152(1):49-55. doi: 10.1016/j.ijcard.2010.07.005. Epub 2010 Aug 3.

PMID:
20674992
5.
6.

Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages.

Cao J, Han Z, Tian L, Chen K, Fan Y, Ye B, Huang W, Wang C, Huang Z.

J Transl Med. 2014 Sep 21;12:266. doi: 10.1186/s12967-014-0266-2.

7.
8.

Suppression of oxLDL-induced MMP-9 and EMMPRIN expression by berberine via inhibition of NF-κB activation in human THP-1 macrophages.

Huang Z, Meng S, Wang L, Wang Y, Chen T, Wang C.

Anat Rec (Hoboken). 2012 Jan;295(1):78-86. doi: 10.1002/ar.21489. Epub 2011 Dec 5. Erratum in: Anat Rec (Hoboken). 2012 Sep;295(9):1405.

9.

Angiotensin II induces EMMPRIN expression in THP-1 macrophages via the NF-kappaB pathway.

Yang LX, Liu H, Guo RW, Ye J, Wang XM, Qi F, Guo CM, Liang X.

Regul Pept. 2010 Aug 9;163(1-3):88-95. doi: 10.1016/j.regpep.2010.04.012. Epub 2010 May 6.

PMID:
20451562
10.

Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway.

Fan Y, Meng S, Wang Y, Cao J, Wang C.

Int J Mol Med. 2011 Apr;27(4):607-15. doi: 10.3892/ijmm.2011.621. Epub 2011 Feb 15.

PMID:
21327328
11.

Comparison of ruptured coronary plaques in patients with unstable and stable clinical presentation.

Lee CW, Park CS, Hwang I, Lee H, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Park SJ.

J Thromb Thrombolysis. 2011 Aug;32(2):150-7. doi: 10.1007/s11239-011-0585-6.

PMID:
21505786
12.

Extracellular matrix metalloproteinase inducer (EMMPRIN) is present in smooth muscle cells of human aneurysmal aorta and is induced by angiotensin II in vitro.

Chen XF, Wang JA, Hou J, Gui C, Tang LJ, Chen XQ, Xie XJ, Jiang JJ, Cai JF, Chen HS, Lu HS, Chen H.

Clin Sci (Lond). 2009 May 1;116(11):819-26. doi: 10.1042/CS20080235.

PMID:
19086920
13.

Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells.

Huang Z, Wang C, Wei L, Wang J, Fan Y, Wang L, Wang Y, Chen T.

Biochem Biophys Res Commun. 2008 Sep 26;374(3):517-21. doi: 10.1016/j.bbrc.2008.07.058. Epub 2008 Jul 21.

PMID:
18647594
14.

Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.

Schmidt R, Bültmann A, Ungerer M, Joghetaei N, Bülbül O, Thieme S, Chavakis T, Toole BP, Gawaz M, Schömig A, May AE.

Circulation. 2006 Feb 14;113(6):834-41. Epub 2006 Feb 6.

15.

Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.

Schmidt R, Bültmann A, Fischel S, Gillitzer A, Cullen P, Walch A, Jost P, Ungerer M, Tolley ND, Lindemann S, Gawaz M, Schömig A, May AE.

Circ Res. 2008 Feb 15;102(3):302-9. Epub 2007 Nov 29.

16.

Angiotensin II induces extracellular matrix metalloproteinase inducer expression via an AT1R dependent pathway in aortic atherosclerotic plaque in apolipoprotein E knockout mice.

Yang LX, Yang ZH, Guo RW, Ye JS, Liu H.

J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):67-75. doi: 10.1177/1470320311423780. Epub 2011 Oct 21.

PMID:
22020146
17.

Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages.

Huang Z, Wang L, Meng S, Wang Y, Chen T, Wang C.

Int J Cardiol. 2011 Jan 21;146(2):153-8. doi: 10.1016/j.ijcard.2009.06.023. Epub 2009 Jul 3.

PMID:
19576641
18.

Functional relevance of protein glycosylation to the pro-inflammatory effects of extracellular matrix metalloproteinase inducer (EMMPRIN) on monocytes/macrophages.

Ge H, Yuan W, Liu J, He Q, Ding S, Pu J, He B.

PLoS One. 2015 Feb 6;10(2):e0117463. doi: 10.1371/journal.pone.0117463. eCollection 2015.

19.

Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma.

Major TC, Liang L, Lu X, Rosebury W, Bocan TM.

Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1200-7.

20.

[Resveratrol inhibits expression of EMMPRIN from macrophages].

Ge H, Zhang JF, Guo BS, He B, Wang BY, Wang CQ.

Yao Xue Xue Bao. 2006 Jul;41(7):625-30. Chinese.

PMID:
17007354
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk